Mia's Feed
Medical News & Research

Innovative Portable Device Enables High-Quality Platelet-Rich Plasma Extraction

Innovative Portable Device Enables High-Quality Platelet-Rich Plasma Extraction

Share this article

A groundbreaking portable device enables quick, affordable, and efficient extraction of high-quality platelet-rich plasma directly from blood, promising advancements in regenerative medicine and personalized healthcare.

2 min read

Recent advancements in medical technology have introduced a novel, cost-effective, and portable system capable of producing high-quality platelet-rich plasma (PRP) directly from whole blood. Traditionally, obtaining PRP involved centrifugation techniques that are not only expensive but can also prematurely activate platelets, diminishing their therapeutic potential.

A research team led by Ikerbasque Research Professor Lourdes Basabe and Fernando Benito from the University of the Basque Country has developed a device that isolates PRP without the need for complex machinery. This innovative system leverages gravity sedimentation, a well-known physical process where denser components settle at the bottom of a container under gravity, to efficiently separate PRP from blood. The design incorporates laser-cut acrylic sheets and specialized adhesives, which allows for low-cost manufacturing.

This device can extract approximately 300 microliters of PRP from one milliliter of blood in just 40 minutes, significantly simplifying the process and reducing handling time. Notably, the system minimizes platelet activation to only 8.2%, compared to 31% with conventional methods, while maintaining the average volume of platelets vital for effective therapy. It also effectively eliminates 98% of red blood cells and 96% of white blood cells, ensuring a purified PRP sample. Furthermore, the system’s modular design allows adjustment based on different blood volumes, maintaining consistent efficiency.

This portable, disposable device represents a significant breakthrough in regenerative medicine, especially suited for resource-limited settings, personalized treatments, or home healthcare. The technology stems from over a decade of research into lab-on-a-chip microfluidic technologies, which condense laboratory functions into compact devices comparable in size to a credit card. The main researcher, Dr. Pablo Enrique Guevara-Pantoja, emphasizes the device’s capacity to generate low-activation platelet-rich plasma with minimal system complexity.

The development is protected under a Spanish patent, and the research team is actively seeking partnerships to scale up production and facilitate market entry. This innovation could revolutionize PRP therapy by making it more accessible, affordable, and efficient.

Source: https://medicalxpress.com/news/2025-07-portable-effective-generate-high-quality.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Gene Therapy Shows Promise in Slowing Motor Decline in ALS Patients

New gene therapy approaches targeting TDP-43 and ATXN2 proteins show promise in slowing motor decline in ALS, offering hope for more effective treatments.

Fatal Measles Case in Canada: Infant Dies from Virus Contracted at Birth Due to Unvaccinated Mother

A tragic case in Canada highlights the dangers of measles, as an infant born prematurely from an unvaccinated mother succumbs to the virus amid rising outbreaks. Experts stress the importance of vaccination to prevent such tragedies.

New Insights from Heart Rhythm Testing Could Help Prevent Sudden Death in Individuals Under 35

Innovative analysis of heart rhythm tests identifies early signs of heart disease in young people, offering new hope for preventing sudden cardiac death among those under 35.

Progress in Prenatal Treatment for Severe Genetic Disorders

Advances in prenatal therapy now enable safe injection of therapeutic molecules into the amniotic fluid, offering early treatment options for severe genetic disorders like spinal muscular atrophy before birth.